ArticleFrontiers in endocrinology2022

Metabolic remodeling of glycerophospholipids acts as a signature of dulaglutide and liraglutide treatment in recent-onset type 2 diabetes mellitus.

Juan Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.